Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Brueckmann, Martina"'
Autor:
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: gregory.lip@liverpool.ac.uk., Mauri L; Brigham and Women's Hospital, Boston, MA., Montalescot G; Sorbonne University-Paris VI, ACTION Study Group, Pitié-Salpêtrière Hospital, Paris, France., Ozkor M; St Bartholomew's Hospital, London, United Kingdom., Vardas P; Heart Sector, Hygeia Group Hospitals, Athens, Greece., Steg PG; FACT, an F-CRIN Network, DHU FIRE, Université Paris Diderot, INSERM U_1148 and Hôpital Bichat Assistance Publique-Hôpitaux de Paris, Paris, France., Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA., Hohnloser SH; Johann Wolfgang Goethe University, Department of Cardiology, Division of Clinical Electrophysiology, Frankfurt/Main, Germany., Miede C; HMS Analytical Software GmbH, Weimar, (Lahn), Germany., Nordaby M; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany; Faculty of Medicine, University of Heidelberg, Mannheim, Germany., Kreuzer J; Boehringer Ingelheim Singapore Pte. Ltd, Singapore., Kimura T; Kyoto University, Department of Cardiovascular Medicine, Kyoto, Japan., Oldgren J; Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Ten Berg JM; St. Antonius Ziekenhuis, Nieuwegein, The Netherlands., Cannon CP; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA.
Publikováno v:
American heart journal [Am Heart J] 2019 Jun; Vol. 212, pp. 13-22. Date of Electronic Publication: 2019 Mar 01.
Autor:
Oldgren J; Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Dag Hammarskjölds väg 38, SE-751 85 Uppsala, Sweden., Steg PG; FACT, an F-CRIN Network, Université Paris Diderot, INSERM U_1148 and Hôpital Bichat Assistance Publique, Paris, France.; Royal Brompton Hospital, Imperial College, Sydney Street, London, UK., Hohnloser SH; Department of Medicine, Division of Cardiology, Johann Wolfgang Goethe University, Theodor Stern-Kai 7, DE-60590 Frankfurt/Main, Germany., Lip GYH; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart & Chest Hospital, Liverpool, UK.; Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Søndre Skovvej 15, Aalborg, Denmark., Kimura T; Department of Cardiovascular Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan., Nordaby M; Boehringer Ingelheim International GmbH, TA CardioMetabolism, Binger Str. 173, Ingelheim, Germany., Brueckmann M; Boehringer Ingelheim International GmbH, TA CardioMetabolism, Binger Str. 173, Ingelheim, Germany.; Faculty of Medicine, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany., Kleine E; Boehringer Ingelheim International GmbH, TA CardioMetabolism, Binger Str. 173, Ingelheim, Germany., Ten Berg JM; Department of Cardiology, St. Antonius Ziekenhuis, Koekoekslaan 1, Nieuwegein 3435 CM, The Netherlands., Bhatt DL; Brigham and Women's Hospital, Heart and Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA, USA., Cannon CP; Brigham and Women's Hospital, Heart and Vascular Center and Harvard Medical School, 75 Francis Street, Boston, MA, USA.; Baim Institute for Clinical Research, 930-W Commonwealth Avenue, Boston, MA, USA.
Publikováno v:
European heart journal [Eur Heart J] 2019 May 14; Vol. 40 (19), pp. 1553-1562.
Autor:
Cannon CP; Harvard Clinical Research Institute, Boston, Massachusetts. christopher.cannon@hcri.harvard.edu.; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. christopher.cannon@hcri.harvard.edu.; Harvard Medical School, Boston, Massachusetts. christopher.cannon@hcri.harvard.edu., Gropper S; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Bhatt DL; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Ellis SG; Cleveland Clinic, Cleveland, Ohio., Kimura T; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Lip GY; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom., Steg PG; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Université Paris-Diderot, Sorbonne Paris-Cité, INSERM U-1148, Paris, France.; NHLI Imperial College, ICMS Royal Brompton Hospital, London, United Kingdom., Ten Berg JM; St. Antonius Hospital, Nieuwegein, The Netherlands., Manassie J; Medical Division Boehringer Ingelheim Ltd, Bracknell, Berkshire, United Kingdom., Kreuzer J; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Faculty of Medicine, University of Heidelberg, Heidelberg, Germany., Blatchford J; Medical Division Boehringer Ingelheim Ltd, Bracknell, Berkshire, United Kingdom., Massaro JM; Boston University School of Public Health, Boston, Massachusetts., Brueckmann M; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.; Faculty of Medicine Mannheim of the University of Heidelberg, Mannheim, Germany., Ferreiros Ripoll E; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Oldgren J; Department of Medical Sciences and Uppsala Clinical Research Centre, Uppsala University Hospital, Uppsala, Sweden., Hohnloser SH; Department of Cardiology, J.W. Goethe University, Frankfurt, Germany.
Publikováno v:
Clinical cardiology [Clin Cardiol] 2016 Oct; Vol. 39 (10), pp. 555-564. Date of Electronic Publication: 2016 Aug 26.